These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38759132)

  • 41. Analysis of Extrastriatal
    Joling M; Vriend C; van den Heuvel OA; Raijmakers PGHM; Jones PA; Berendse HW; Booij J
    J Nucl Med; 2017 Jul; 58(7):1117-1123. PubMed ID: 27856628
    [No Abstract]   [Full Text] [Related]  

  • 42. Swallow tail sign on susceptibility map-weighted imaging (SMWI) for disease diagnosing and severity evaluating in parkinsonism.
    Liu X; Wang N; Chen C; Wu PY; Piao S; Geng D; Li Y
    Acta Radiol; 2021 Feb; 62(2):234-242. PubMed ID: 32380911
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dopamine transporter SPECT imaging in Parkinson’s disease and parkinsonian disorders.
    Akdemir ÜÖ; Bora Tokçaer A; Atay LÖ
    Turk J Med Sci; 2021 Apr; 51(2):400-410. PubMed ID: 33237660
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic Potential of Multimodal MRI Markers in Atypical Parkinsonian Disorders.
    Seki M; Seppi K; Mueller C; Potrusil T; Goebel G; Reiter E; Nocker M; Kremser C; Wildauer M; Schocke M; Gizewski ER; Wenning GK; Poewe W; Scherfler C
    J Parkinsons Dis; 2019; 9(4):681-691. PubMed ID: 31450511
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reproducible network and regional topographies of abnormal glucose metabolism associated with progressive supranuclear palsy: Multivariate and univariate analyses in American and Chinese patient cohorts.
    Ge J; Wu J; Peng S; Wu P; Wang J; Zhang H; Guan Y; Eidelberg D; Zuo C; Ma Y
    Hum Brain Mapp; 2018 Jul; 39(7):2842-2858. PubMed ID: 29536636
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD.
    Yekhlef F; Ballan G; Macia F; Delmer O; Sourgen C; Tison F
    J Neural Transm (Vienna); 2003 Feb; 110(2):151-69. PubMed ID: 12589575
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dopamine Transporter Imaging in Parkinson Disease: Progressive Changes and Therapeutic Modification after Anti-parkinsonian Medications.
    Ikeda K; Ebina J; Kawabe K; Iwasaki Y
    Intern Med; 2019 Jun; 58(12):1665-1672. PubMed ID: 30799370
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preliminary studies of differential impairments of the dopaminergic system in subtypes of progressive supranuclear palsy.
    Lin WY; Lin KJ; Weng YH; Yen TC; Shen LH; Liao MH; Lu CS
    Nucl Med Commun; 2010 Nov; 31(11):974-80. PubMed ID: 20717064
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dual-tracer dopamine transporter and perfusion SPECT in differential diagnosis of parkinsonism using template-based discriminant analysis.
    Van Laere K; Casteels C; De Ceuninck L; Vanbilloen B; Maes A; Mortelmans L; Vandenberghe W; Verbruggen A; Dom R
    J Nucl Med; 2006 Mar; 47(3):384-92. PubMed ID: 16513606
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Laterality of specific binding ratios on DAT-SPECT for differential diagnosis of degenerative parkinsonian syndromes.
    Shigekiyo T; Arawaka S
    Sci Rep; 2020 Sep; 10(1):15761. PubMed ID: 32978422
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Referral practice, reporting standards, and the impact of dopamine transporter scans done in a tertiary hospital.
    Bhattacharjee S; Chalissery AJ; Barry T; O'Sullivan D; O'Connell M; Lynch T
    Neurol India; 2017; 65(6):1264-1270. PubMed ID: 29133699
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The utility of the combination of a SPECT study with [123I]-FP-CIT of dopamine transporters and [123I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes.
    Uyama N; Otsuka H; Shinya T; Otomi Y; Harada M; Sako W; Izumi Y; Kaji R; Watanabe Y; Takashi S; Kunikane Y
    Nucl Med Commun; 2017 Jun; 38(6):487-492. PubMed ID: 28410288
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correlations between cerebrospinal fluid homovanillic acid and dopamine transporter SPECT in degenerative parkinsonian syndromes.
    Goto R; Kurihara M; Kameyama M; Komatsu H; Higashino M; Hatano K; Ihara R; Higashihara M; Nishina Y; Matsubara T; Kanemaru K; Saito Y; Murayama S; Iwata A
    J Neural Transm (Vienna); 2023 Apr; 130(4):513-520. PubMed ID: 36871130
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SPECT Molecular Imaging in Atypical Parkinsonism.
    Brumberg J; Isaias IU
    Int Rev Neurobiol; 2018; 142():37-65. PubMed ID: 30409259
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential Diagnosis of Parkinsonism Using Dual-Phase F-18 FP-CIT PET Imaging.
    Jin S; Oh M; Oh SJ; Oh JS; Lee SJ; Chung SJ; Lee CS; Kim JS
    Nucl Med Mol Imaging; 2013 Mar; 47(1):44-51. PubMed ID: 24895507
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of DAT-SPECT in movement disorders.
    Kägi G; Bhatia KP; Tolosa E
    J Neurol Neurosurg Psychiatry; 2010 Jan; 81(1):5-12. PubMed ID: 20019219
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical impact of diagnostic SPET investigations with a dopamine re-uptake ligand.
    Løkkegaard A; Werdelin LM; Friberg L
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1623-9. PubMed ID: 12458397
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ACR-ACNM Practice Parameter for the Performance of Dopamine Transporter (DaT) Single Photon Emission Computed Tomography (SPECT) Imaging for Movement Disorders.
    Subramaniam RM; Frey KA; Hunt CH; Mercier GA; Solnes LB; Colletti PM; Lu Y; Savir-Baruch B; Williams HT
    Clin Nucl Med; 2017 Nov; 42(11):847-852. PubMed ID: 28922189
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correlation of 3D FLAIR and Dopamine Transporter Imaging in Patients With Parkinsonism.
    Oh SW; Shin NY; Lee JJ; Lee SK; Lee PH; Lim SM; Kim JW
    AJR Am J Roentgenol; 2016 Nov; 207(5):1089-1094. PubMed ID: 27489952
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Contribution of the Mesencephalon Indices to Differential Diagnosis of Parkinsonian Disorders.
    Oktay C; Özkaynak SS; Eseroğlu E; Karaali K
    Can Assoc Radiol J; 2020 Feb; 71(1):100-109. PubMed ID: 32062996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.